Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean bis taurus bone?
Displaying drugs 1 - 25 of 422 in total
Bos taurus skin or pelt is used in allergenic testing.
Approved
Matched Name: … Bos taurus skin …
Matched Description: … Bos taurus skin or pelt is used in allergenic testing. …
Matched Products: … Bos Taurus Skin …
Elapegademase is a PEGylated recombinant adenosine deaminase. It can be defined molecularly as a genetically modified bovine adenosine deaminase with a modification in cysteine 74 for serine and with about 13 methoxy polyethylene glycol chains bound via carbonyl group in alanine and lysine residues. Elapegademase is generated in E. coli,...
Approved
Matched Synonyms: … (74-SERINE (C>S),245-THREONINE (A>T))BOS TAURUS ADENOSINE DEAMINASE (BOVINE ADENOSINE AMINOHYDROLASE, ... (CYS74>SER,ALA245>THR)ADENOSINE DEAMINASE (BOS TAURUS, BOVINE)-(1-356)-PEPTIDE, PRODUCED IN ESCHERICHIA …
Skim milk allergenic extract is used in allergenic testing.
Approved
Matched Synonyms: … Bos taurus milk, fat removed …
Samarium Sm 153 lexidronam is a radioactive medication used to treat pain caused by cancer that has spread to the bone. It is a radiopharmaceutical. Radiopharmaceuticals are radioactive agents that may be used to diagnose some diseases by studying the function of the body's organs or to treat certain diseases.Samarium...
Approved
Investigational
Matched Description: … 153 lexidronam is a radioactive medication used to treat pain caused by cancer that has spread to the bone ... The radioactive samarium is taken up in the bone cancer area and gives off radiation that helps provide ... the body's organs or to treat certain diseases.Samarium Sm 153 lexidronam is used to help relieve the bone
Matched Categories: … Pain Palliation (Bone Seeking Agents) …
Matched Products: … T-BONE KAEF …
Boscalid has been investigated for the treatment of OSDI, Glaucoma, Staining, Schirmers, and Disease Severity, among others.
Approved
Experimental
Clodronic acid is a first generation bisphosphonate similar to etidronic acid and tiludronic acid. These drugs were developed to mimic the action of pyrophosphate, a regulator of calcification and decalcification. clodronate’s use has decreased over the years in favor of the third generation, nitrogen containing bisphosphonate zoledronic acid, ibandronic acid,...
Approved
Investigational
Vet approved
Matched Categories: … Bone Density Conservation Agents ... Drugs for Treatment of Bone Diseases ... Drugs Affecting Bone Structure and Mineralization …
Strontium ranelate, a strontium (II) salt of ranelic acid, is a medication for osteoporosis. Some reports have shown that strontium ranelate can slow down the progression of osteoarthritis of the knee. This agent presents an atypical mechanism of action in which it increases deposition of new bone by osteoblasts and,...
Approved
Withdrawn
Matched Description: … and, simultaneously, reduces the resorption of bone by osteoclasts. ... It is therefore promoted as a "dual action bone agent" (DABA) indicated for use in treatment of severe ... clinical studies demonstrate the ability of strontium ranelate to improve and strengthen intrinsic bone
Matched Categories: … Bone Density Conservation Agents ... Drugs for Treatment of Bone Diseases ... Drugs Affecting Bone Structure and Mineralization …
Pamidronic acid is a second generation, nitrogen containing bisphosphonate similar to neridronic acid and alendronic acid. Pamidronic acid was first described in the literature in 1977. The second generation bisphosphonates are less common as third generation bisphosphonates, such as ibandronic acid, zoledronic acid, minodronic acid, and risedronic acid are becoming...
Approved
Matched Categories: … Bone Density Conservation Agents ... Drugs for Treatment of Bone Diseases ... Drugs Affecting Bone Structure and Mineralization …
Zoledronic acid, or CGP 42'446, is a third generation, nitrogen containing bisphosphonate similar to ibandronic acid, minodronic acid, and risedronic acid. Zoledronic acid is used to treat and prevent multiple forms of osteoporosis, hypercalcemia of malignancy, multiple myeloma, bone metastases from solid tumors, and Paget’s disease of bone.[L13712,L13715,L13721] Zoledronic acid...
Approved
Matched Description: … metastases from solid tumors, and Paget’s disease of bone. ... to treat and prevent multiple forms of osteoporosis, hypercalcemia of malignancy, multiple myeloma, bone
Matched Categories: … Bone Density Conservation Agents ... Drugs for Treatment of Bone Diseases ... Drugs Affecting Bone Structure and Mineralization …
Ibandronate, or BM 21.0955, is a third generation, nitrogen containing bisphosphonate similar to zoledronic acid, minodronic acid, and risedronic acid.[A203111,A203138] It is used to prevent and treat postmenopausal osteoporosis.[L13805,L13808] Ibandronate was first described in the literature in 1993 as a treatment for bone loss in dogs. Ibandronate was granted FDA...
Approved
Investigational
Matched Description: … [L13805,L13808] Ibandronate was first described in the literature in 1993 as a treatment for bone loss …
Matched Categories: … Bone Density Conservation Agents ... Drugs for Treatment of Bone Diseases ... Drugs Affecting Bone Structure and Mineralization …
Denosumab is a novel, fully human IgG2 monoclonal antibody specific to receptor activator of nuclear factor kappa-B ligand (RANKL), suppresses bone resorption via inhibiting RANK-mediated activation of osteoclasts. It is the first and currently the only RANKL inhibitor approved to prevent osteoclast-mediated bone loss. Chemically, it consists of 2 heavy...
Approved
Matched Description: … monoclonal antibody specific to receptor activator of nuclear factor kappa-B ligand (RANKL), suppresses bone ... It is the first and currently the only RANKL inhibitor approved to prevent osteoclast-mediated bone loss ... It further received additional indication approval to increase bone mass in men at high risk for fracture …
Matched Categories: … Bone Density Conservation Agents ... Drugs for Treatment of Bone Diseases ... Drugs Affecting Bone Structure and Mineralization …
Alfacalcidol, or 1-alpha-hydroxycholecalciferol or 1-alpha-hydroxyvitamin D3, is a non-endogenous analogue of vitamin D. It plays an essential function in calcium homeostasis and bone metabolism. Alfacaldisol is activated by the enzyme 25-hydroxylase in the liver to mediate its effects in the body, or most importantly, the kidneys and bones. The pharmacological...
Approved
Nutraceutical
Matched Description: … [A234044] It plays an essential function in calcium homeostasis and bone metabolism. …
Matched Categories: … Bone Density Conservation Agents ... Drugs for Treatment of Bone Diseases ... Drugs Affecting Bone Structure and Mineralization …
Burosumab (KRN23) is an entirely human monoclonal IgG1 antibody that binds excess fibroblast growth factor 23 (FGF23) and has been successfully tested in clinical trials in children with X-linked hypophosphatemic rickets . The U.S. Food and Drug Administration approved Crysvita (burosumab) in April 2018. This is the first drug approved...
Approved
Investigational
Matched Description: … It causes impaired bone growth and development in children and adolescents and issues with bone mineralization ... Most children with XLH suffer from bowed or bent legs, short stature, bone pain and severe dental pain …
Matched Categories: … Drugs for Treatment of Bone Diseases ... Drugs Affecting Bone Structure and Mineralization …
Abaloparatide is an N-terminal analog of parathyroid hormone-related protein (PTHrP) and an agonist at the parathyroid hormone type 1 (PTH1) receptor. It is a synthetic 34 amino acid peptide with 41% homology to human parathyroid hormone 1-34 and human PTHrP 1-34. Abaloparatide and PTHrP share the first 21 amino acids...
Approved
Investigational
Matched Description: … [A256778] Abaloparatide is an osteoanabolic agent that stimulates bone formation. ... 2017,[A256748] for the treatment of osteoporosis in postmenopausal women and is also used to increase bone
Matched Categories: … Bone Density Conservation Agents …
Calcitonin was first discovered in isolated parathyroid tissue as a substance with a serum-calcium-lowering effect. It is constituted as a 32-amino acid single chain polypeptide structure that gets secreted as a regulatory agent in calcium-phosphorus metabolism. It is used as an alternative for people developing antibodies against salmon calcitonin.
Approved
Investigational
Matched Categories: … Bone Density Conservation Agents …
Strontium chloride (SrCl2) is a salt of strontium and chloride. SrCl2 is useful in reducing tooth sensitivity by forming a barrier over microscopic tubules in the dentin containing nerve endings that have become exposed by gum recession [A33167, A33168]. This kind of barrier protection for tooth hypersensitivity has, however, been...
Approved
Sargramostim is a human recombinant granulocyte macrophage colony-stimulating factor (GM-CSF) expressed in yeast. It is a glycoprotein that is 127 residues. Substitution of Leu23 leads to a difference from native protein.
Approved
Investigational
Lasofoxifene is a non-steroidal 3rd generation selective estrogen receptor modulator (SERM) that selectively binds to both ERα and ERβ with high affinity. It is a naphthalene derivative marketed for prevention and treatment of osteoporosis and for the treatment of vaginal atrophy. It was initially developed as Oporia by Pfizer as...
Approved
Investigational
Loracarbef is a carbacephem antibiotic sometimes grouped together with the second-generation cephalosporin antibiotics. It is marketed under the trade name Lorabid.
Approved
Investigational
Withdrawn
Vitamin D, in general, is a secosteroid generated in the skin when 7-dehydrocholesterol located there interacts with ultraviolet irradiation - like that commonly found in sunlight . Both the endogenous form of vitamin D (that results from 7-dehydrocholesterol transformation), vitamin D3 (cholecalciferol), and the plant-derived form, vitamin D2 (ergocalciferol), are...
Approved
Nutraceutical
Matched Description: … healthy physiologic range to sustain a variety of metabolic functions, transcription regulation, and bone
Matched Mixtures name: … One A Day Bone Builder …
Matched Categories: … Bone Density Conservation Agents ... Drugs for Treatment of Bone Diseases ... Drugs Affecting Bone Structure and Mineralization …
Raloxifene is a second generation selective estrogen receptor modulator (SERM) that mediates anti-estrogenic effects on breast and uterine tissues, and estrogenic effects on bone, lipid metabolism, and blood coagulation.[A4979,T28] Exhibiting tissue-specific effects distinct from estradiol, raloxifene is the first of the benzothiophene group of antiestrogens to be labelled a SERM....
Approved
Investigational
Matched Description: … SERM) that mediates anti-estrogenic effects on breast and uterine tissues, and estrogenic effects on bone ... [T28] The main effects of raloxifene are to preserve the bone mineral density and decrease the risk ... causes of osteoporosis include postmenopausal deficiency of estrogen and age-related deterioration in bone
Matched Categories: … Bone Density Conservation Agents …
Approved
Vet approved
Parathyroid hormone (PTH) is a single-chain polypeptide composed of 84 amino acids. Available as Preotact, it is an identical form of human recombinant hormome which produced as a fusion protein undergoeing post-translational processing involving the cleavage of the OmpA leader sequence, leaving the mature protein as a single-chain 84 amino-acids...
Approved
Investigational
A vitamin D that can be regarded as a reduction product of vitamin D2.
Approved
Matched Categories: … Bone Density Conservation Agents …
Displaying drugs 1 - 25 of 422 in total